|Mr. Joseph Moscato||CEO, Pres & Chairman||N/A||N/A||1964|
|Mr. Mark Corrao||CFO & Treasurer||N/A||N/A||1959|
|Mr. Andrew Ro||Chief Investment Officer, Sr. VP of Investments & Director||N/A||N/A||1971|
|Mr. Mark A. Fletcher Esq.||Exec. VP, Gen. Counsel & Sec.||71.46k||N/A||1965|
|Mr. Richard D. Purcell||Sr. VP of Research & Drug Devel.||N/A||N/A||1961|
Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virus?½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.
Generex Biotechnology Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.